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The diversity of ubiquitin (Ub)-dependent signaling is
attributed to the ability of this small protein to form
different types of covalently linked polyUb chains
and to the existence of Ub binding proteins that inter-
pret this molecular syntax. We used affinity capture/
mass spectrometry to identify ALIX, a component of
the ESCRT pathway, as a Ub binding protein. We
report that the V domain of ALIX binds directly and
selectively to K63-linked polyUb chains, exhibiting
a strong preference for chains composed of more
than three Ub. Sequence analysis identified two
potential Ub binding sites on a single a-helical
surface within the coiled-coil region of the V domain.
Mutation of these putative Ub binding sites inhibited
polyUb binding to the isolated V domain in vitro and
impaired budding of lentiviruses. These data reveal
an important role for K63 polyUb binding by ALIX in
retroviral release.
INTRODUCTION
Ubiquitin (Ub) is a highly conserved 76 amino acid protein that,
when conjugated to cellular substrates, functions in a broad
range of signaling pathways (Komander and Rape, 2012). This
diversity is achieved in part by Ub’s ability to form polyUb chains
in which Ub is conjugated to itself through either its amino
terminus or any of its seven internal lysines (Ye and Rape,
2009). This Ub code is typically read by proteins that contain
one or more Ub binding domains (UBDs) that, individually, bind
monoUb with low affinity (300–1000 mM) (Husnjak and Dikic,
2012) and when arranged in tandem within a single polypeptide
chain, impart linkage-selective binding via an avidity-based
mechanism (Sims and Cohen, 2009).
In this study,weusedaK63polyUbaffinity capture reagent and
liquid chromatography-tandemmass spectrometry (LC-MS/MS)
to identify ALIX, a component of the endosomal-sorting complex
required for transport (ESCRT) machinery (Henne et al., 2011), as
a K63-selective polyUb binding protein. ALIX comprises threeDevelopmentadistinct structural elements (Figure 1): anN-terminal Bro1 domain
that binds CHMP4 subunits of the ESCRT-III complex (McCul-
lough et al., 2008), a central V domain that binds YPXnL motifs
found in viral Gag proteins and some MVB cargoes (Dores
et al., 2012; Fisher et al., 2007; Lee et al., 2007), and a C-terminal
proline-rich region (PRR) that can fold back onto the upstream
domains and autoinhibit ligand binding (Zhai et al., 2011; Zhou
et al., 2009). ALIX has been shown to function in retrovirus
budding (Strack et al., 2003), cytokinesis (Carlton et al., 2007;
Morita et al., 2007; Lee et al., 2008), sorting ofmembraneproteins
into MVBs (Dores et al., 2012), and in the generation of MVB-
derivedexosomal vesicles (Baietti et al., 2012). Importantly, these
ESCRT-dependent pathways are regulated by Ub (Mukai et al.,
2008; Pohl and Jentsch, 2008; Shields and Piper, 2011), and
there is accumulating evidence that K63-linked chains are the
relevant Ub species (Erpapazoglou et al., 2012; Ren and Hurley,
2010; Strack et al., 2002; Weiss et al., 2010).
There are a number of indications that Ub is involved in retro-
virus budding, although its precise role(s) is not yet fully under-
stood (Martin-Serrano, 2007). For example, retroviruses can
use Ub E3 ligases of the NEDD4 family to link into the ESCRT
pathway (Chung et al., 2008; Martin-Serrano et al., 2005; Rauch
and Martin-Serrano, 2011; Usami et al., 2008), and nonbudding
viral mutants can be rescued by fusing Ub directly to the
C-terminal end of the viral Gag protein (Joshi et al., 2008; Patnaik
et al., 2000). Freed and coworkers have reported that immobi-
lized monoUb can capture ALIX from crude cell extracts (Joshi
et al., 2008). Here, we show that the V domain of ALIX binds
directly and preferentially to K63-linked polyUb chains via clus-
ters of three amino acids (termed ‘‘triads’’), within the ALIX V
domain that are similar to triads that contact linear diUb in
UBAN (ubiquitin binding in ABIN and NEMO) (Rahighi et al.,
2009). Mutation of the ALIX triads impaired retroviral release,
indicating that direct Ub binding by ALIX is required for viral
budding.
RESULTS
The ALIX V Domain Specifically Interacts
with K63-Linked TetraUb
To identify K63 chain-specific polyUb binding proteins, we used
a K63-linked polyubiquitylated protein, P16-Ubn, to capturel Cell 23, 1247–1254, December 11, 2012 ª2012 Elsevier Inc. 1247
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Figure 1. ALIX Binds K63-Linked Chains via
the V Domain
(A) ALIX domain organization and constructs. Bro1
domain, V domain, proline-rich region (PRR),
StrepTactin tag (St), and His6 tag (H6) are shown.
(B) Immobilized P16-Ubn captures Strep-ALIX
constructs expressed in mammalian cells. Left:
analysis of ALIX proteins bound to immobilized
P16-Ubn or P16 from HEK293T cell lysates ex-
pressing Strep-WT or Strep-DPRR ALIX. Right:
5% input. Proteins were separated by SDS-PAGE
and analyzed by immunoblot with anti-StrepTactin
or anti-tubulin. Nonspecific background band is
denoted by an asterisk (*). WT, wild-type.
(C) ALIXV binds directly to immobilized P16-Ubn.
Left: analysis of recombinantly expressed and
purified ALIXV binding to immobilized P16-Ubn or
P16. Right: 100% protein input. Proteins were
separated by SDS-PAGE and visualized by Coo-
massie blue staining.
(D) Autoubiquitylated GST-Rsp5 binds to immo-
bilized recombinant ALIXV. GST-Rsp5 was autou-
biquitylated (+ATP), and GST-Rsp5-Ubn was
deubiquitylated by Usp2cc as indicated. Bound
proteins were separated by SDS-PAGE and
analyzed by immunoblot with anti-GST. Ctrl,
control.
See Figure S1 and Table S1 for details.
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ALIX Binds Lys63-Linked Polyubiquitin Chainsproteins from a HEK293 cell lysate (Figure S1 available online).
LC-MS/MS analysis identified 87 proteins (Table S1) captured
with P16-Ubn, of which 15 were selected as candidate polyUb
binding proteins based on their identification in at least two out
of three replicates and on their lack of binding to enzymatically
deubiquitylated P16-Ubn and nonubiquitylated P16. This list
contains ten proteins previously shown to interact with Ub,
including two polyUb binding receptors associated with the
26S proteasome (RAD23 and RPN10), five proteins associated
with ESCRT or endosomal trafficking machinery (hVPS37b,
HRS, TSG101, TOM1, and EPS15), as well as a deubiquitinating
enzyme (UCHL1) and an autophagy receptor (p62) (Husnjak and
Dikic, 2012). The identification of known Ub binding proteins1248 Developmental Cell 23, 1247–1254, December 11, 2012 ª2012 Elsevier Inc.indicated that the P16-Ubn affinity
capture procedure worked well and sug-
gested that the remaining proteins might
also bind Ub. The remaining known Ub
binding protein, CCDC50, binds selec-
tively to K63 chains via a coiled-coil
domain similar to UBAN (Bohgaki et al.,
2008). Because both ALIX and HD-PTP
also contain coiled-coil elements, we
considered the possibility that they might
also bind polyUb in a similar fashion. This
idea was particularly attractive because
ALIX was by far the most abundant
protein identified in our analysis.
To verify ALIX binding to K63 polyUb,
we tested whether immobilized P16-Ubn
could capture Strep-tagged ALIX from
lysates of HEK293T cells that expressedeither the wild-type protein (Strep-WT) or a construct that lacked
the autoinhibitory C-terminal proline-rich region (Strep-DPRR)
(Figure 1A). As shown in Figure 1B, Strep-WT and Strep-DPRR
ALIX both bound P16-Ubn, but not P16, confirming our proteo-
mic identification of ALIX (Table S1) as a Ub binding protein and
indicating that the C-terminal PRR is dispensable for binding.
As shown in Figure 1C, we found that pure recombinant His6-V
domain (ALIXV, residues 360–702; Figure 1C, right panel) bound
immobilized P16-Ubn, but not P16, indicating that the V domain
is sufficient for binding polyUb and that the interaction is direct.
This conclusion was confirmed in a reciprocal pull-down
experiment in which immobilized ALIXV bound autoubiquitylated
GST-Rsp5 (GST-Rsp5-Ubn) (Figures S1F and S1G) but not
AC
E
G
B
F
H
D
Ub4
K48 K63 Linear
0
2
4
6
8
10
ALIXV
TUBE UBA
N
or
m
al
iz
ed
 B
in
di
ng
 (A
U
)
Time (s)
100 200 300 400
S
P
R
 S
ig
na
l (
R
U
)
100 200 300 400
0
5
10
15
20
25
30
K63 Ub3
Time (s)
S
P
R
 S
ig
na
l (
R
U
)
0
5
10
15
20
25
30
K63 Ub2
Time (s)
100 200 300 400
S
P
R
 S
ig
na
l (
R
U
)
0
5
10
15
20
25
30
Ub
0 μM
25 μM
50 μM
250 μM
500 μM
750 μM
1000 μM
100 μM
[K63 Ubn] (μM)
0 5 10 15 20 25 30
S
S
 S
P
R
 S
ig
na
l /
 M
W
(R
U
 / 
kD
)
-0.1
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
K63 Ub2
K63 Ub2
K63 Ub3
K63 Ub3
K63 Ub4
K63 Ub4
Time (s)
100 200 300 400
S
P
R
 S
ig
na
l (
R
U
)
0
5
10
15
20
25
30
0 μM
0.78125 μM
1.5625 μM
3.125 μM
6.25 μM
12.5 μM
25 μMK48 Ub4
Time (s)
100 200 300 400
S
P
R
 S
ig
na
l (
R
U
)
0
5
10
15
20
25
30
K63 Ub4
0 μM
0.78125 μM
1.5625 μM
3.125 μM
6.25 μM
12.5 μM
25 μM
Time (s)
100 200 300 400
S
P
R
 S
ig
na
l (
R
U
)
0
5
10
15
20
25
30
Linear Ub4
0 μM
0.78125 μM
1.5625 μM
3.125 μM
6.25 μM
12.5 μM
25 μM
0 μM
0.78125 μM
1.5625 μM
3.125 μM
6.25 μM
12.5 μM
25 μM
0 μM
0.78125 μM
1.5625 μM
3.125 μM
6.25 μM
12.5 μM
25 μM
Figure 2. ALIX V Domain Preferentially
Recognizes K63-Linked TetraUb
(A) ALIXV selectively binds unanchored K63 Ub4
polyUb chains. Ub AQUA pull-down analysis of
biotin-tagged ALIXV (Figure S2A) (black bars) or
TUBE UBA (white bars, control) from a mixture of
Ub4 (K48, K63, and linear). Normalized binding
data are shown (data calculations in Table S2).
Measurements represent mean ± SD (n = 3). a.u.,
arbitrary units.
(B–G) Interaction of immobilized ALIXV with
K48 Ub4 (B), Linear Ub4 (C), K63 Ub4 (D), K63 Ub3
(E), K63 Ub2 (F), and Ub (G). Sensorgrams are
shown for ALIXV immobilized at a density of 150
RU. Ub chains (0.78–25 mM; 2-fold serial dilutions)
and Ub (25–1,000 mM; 2-fold serial dilutions) were
injected in duplicate. RU, response units.
(H) ALIXV prefers to bind to K63 polyUb chains
containing more than three Ub moieties. Equilib-
rium biosensor binding data from (D)–(F) were
normalized to a molecular weight (MW) of Ub4,
Ub3, and Ub2.
See Figure S2 and Table S2 for details.
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ALIX Binds Lys63-Linked Polyubiquitin Chainsenzymatically deubiquitylated GST-Rsp5-Ubn or nonautoubiqui-
tylated GST-Rsp5 (Figure 1D).
To examine polyUb-linkage specificity, we used ALIXV to
capture unanchored Ub homopolymers from a mixture of pure
K48, K63, and linear Ub4. Recombinant biotin-tagged ALIXV (Fig-
ure S2A) was incubated with the Ub4 mixture, and bound Ub
molecules were analyzed by quantitative MS using synthetic
heavy isotope-labeled (AQUA) standards. Normalization of the
raw binding data to input and subtraction of signal attributed to
resin alone (Table S2) revealed that ALIXV bound approximately
8-fold more K63 Ub4 than K48 or linear Ub4 (Figure 2A). By
contrast, a control tandem Ub binding domain (TUBE UBA)
bound all three types of Ub4 linkages to a roughly equal extentDevelopmental Cell 23, 1247–1254, De(Figure 2A). Thus, ALIXV exhibits strong
linkage specificity for K63 over K48 and
linear Ub4 under conditions where all
three forms can compete for binding.
We used biosensor analyses to mea-
sure the interaction of immobilized ALIXV
with pure unanchored K48, linear, or
K63 Ub4 homopolymers. To minimize
avidity effects on the biosensor chip
(Zimmerman and Minton, 1993), biotin-
tagged ALIXV was immobilized at surface
densities of 150 RU (Figures 2B–2D) or
220 RU (Figures S2B–S2D). These exper-
iments again indicated that ALIXV binds
preferentially to K63 Ub chains because
the equilibrium binding responses were
invariably higher for K63 Ub4 (Figures
2D and S2D) than for equivalent
concentrations of either K48 Ub4 (Figures
2B and S2B) or linear Ub4 (Figures 2C
and S2C).
Biosensor analyses were also used
to examine the length dependence ofALIXV binding to K63-linked chains of one to four Ub molecules.
As shown in Figures 2D–2G, ALIXV bound all of the Ub-
containing species, including monoUb, but bound much more
strongly to tetraUb than to the shorter chains, even when the
response signals were corrected for the molecular weight differ-
ences (Figure 2H). We conclude that ALIXV has a preference for
binding to chains that contain at least four K63-linked Ub
molecules.
ALIXV Contains a UBAN-like Coiled-Coil Region
Required for PolyUb Binding
We compared the ALIXV sequence with that of the Ub binding
domain of NEMO, the only structurally defined coiled-coil UBDcember 11, 2012 ª2012 Elsevier Inc. 1249
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Figure 3. UBAN-like Triads Mediate V
Domain K63-Linked PolyUb Binding
(A) ALIXV shares a conserved sequence element
with UBAN. Alignment of amino acid sequence of
NEMO UBAN from Mus musculus (mm) and of
ALIXV from Homo sapiens (hs), Mus musculus
(mm), Rattus norvegicus (rn), Xenopus laevis (xl),
and Penaeus monodon (pm). UniProtKB acces-
sion numbers are indicated. Conserved (red
arrowheads) and proposed (blue arrowheads) Ub
binding triads are indicated. Leu residues corre-
sponding to the heptad repeat are indicated in
green letters.
(B) Structural organization of human ALIXBro1-V
(Protein Data Bank ID code [PDB] 2OEV). Bro1
domain (orange), V domain (cyan), and sites of
CHMP4 binding (I212, dark gray), YPXnL motif
binding (F676, green), and Ub binding triads QEE
(red) and ERE (blue), corresponding to the identi-
fication and color code in (A), are indicated.
(C) The disposition of the first ALIXV triad is similar
to that of UBAN. Structural view of the conserved
regions of NEMO UBAN (gray, PDB 3F89) from
Mus musculus and ALIXV (cyan, PDB 2OEX) from
Homo sapiens. Side (top panels) and end-on
(bottom panels) views of a helices containing
conserved (red) and putative (blue) triad residues.
Color code corresponds to (A).
(D) ALIXV triad mutants are impaired in binding to
immobilized P16-Ubn. Bound proteins were eluted
in SDS sample buffer, separated by SDS-PAGE,
and visualized by Coomassie blue staining.
(E) Quantification of the levels of ALIXV captured by
P16-Ubn in (D) as a ratio to the levels of each
respective input. Measurements represent mean ±
SD (n = 3).
(F) Impaired binding of immobilized ALIXV 6A
mutant to K63 Ub4. Biosensor responses are
shown for ALIXV 6A immobilized at a density of
150 RU. Ub chains (0.78–25 mM; 2-fold serial
dilutions) were injected in duplicate.
(G) Impaired binding of ALIXV 6A to unanchored
Ub4 polyUb chains of the indicated linkages. Ub
AQUA pull-down analysis was performed as in
Figure 2A (data calculations in Table S2) for ALIXV
WT (black bars) or 6A (white bars). Measurements
represent mean ± SD (n = 3). Experimental data
used for ALIXV WT (black bars) were from Fig-
ure 2A for comparison.
See Figure S3 for details.
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ALIX Binds Lys63-Linked Polyubiquitin Chains(Rahighi et al., 2009) (Figure 3A). UBAN is composed of a parallel
dimeric coiled coil that binds preferentially to linear polyUb
chains (Rahighi et al., 2009). Linear chains share a similar open
conformation and inter-Ub distance with K63 (Komander et al.,
2009). Alignment of the NEMO and ALIX sequences identified
several features, including a precise heptad repeat (Figure 3A,
green letters) and a triad of Glu residues (E313, E317, and
E320; Figure 3A, red arrowheads) that are conserved between
NEMO and metazoan ALIX homologs but not, apparently, with
yeast Bro1p. In NEMO, the Glu triad makes extensive polar
contacts with an atypical surface on the proximal Ub, whereas
the region between E289 and E313 engages the canonical I44
hydrophobic patch of the distal Ub (Rahighi et al., 2009). Among
UBAN family members, the presence of a Glu triad in this posi-1250 Developmental Cell 23, 1247–1254, December 11, 2012 ª2012tion is highly conserved, but the motif is partially degenerate in
that Gln is occasionally substituted for Glu. In ALIX, the corre-
sponding QEE triad (Q435, E439, E442) is also degenerate,
in that Glu can be replaced by Gln or Asp. The side chains of
the Glu/Gln triads in NEMO and ALIX are displayed in similar
orientations along the a14 strand in Arm 2 of ALIXV (Figures 3B
and 3C).
Linkage-specific polyUb binding is commonly achieved by
precise spatial arrangement of multiple UBDs, often in tandem
(Sims and Cohen, 2009), and we noted the presence of an addi-
tional Glu-rich triad (designated ERE; E453, R456, E460; Figures
3A–3C, blue arrowheads/residues). To test whether these Glu-
rich clusters contribute to Ub recognition, we tested P16-Ubn
binding to pure ALIXV harboring Ala substitution mutations ofElsevier Inc.
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A B Figure 4. ALIX Ub Binding Mutant Is Defec-
tive in HIV-1DPTAP and EIAV Infectivity and
Release
(A) ALIX6A Ub binding mutant is defective in rescue
of HIV-1DPTAP virus release and infectivity. Viral
infectivity (panel 1) and immunoblots showing
virion release (panel 2, ‘‘Virus,’’ anti-CA and anti-
MA), cellular Gag protein levels (panel 3, ‘‘Cell,’’
anti-CA and anti-MA), exogenous and endoge-
nous ALIX expression levels (panels 4 and 5, anti-
ALIX and anti-FLAG), and cellular GAPDH levels
(panel 6, anti-GAPDH). Measurements represent
mean ± SD (n = 6). Lanes 1–4 show the proviral
HIVDPTAP expression construct cotransfected
with an empty vector (control, lane 1), or with
vectors expressing wild-type FLAG-ALIX (WT,
control, lane 2), FLAG-ALIXI212D (I121D, CHMP4
binding control, lane 3), or FLAG-ALIX6A (6A, Ub
binding mutant, lane 4). Lanes 5–8 show the same
set of vectors cotransfected with the proviral
HIVDPTAP/DYP expression construct, which carries
an inactivating mutation in the ALIX binding site
of p6Gag.
(B) ALIX6A Ub binding mutant is defective in EIAV
virus release and infectivity. EIAV vector titers
(panel 1) and immunoblots showing virion release
(panel 2, ‘‘Virus,’’ anti-CA), cellular Gag protein
levels (panel 3, ‘‘Cell,’’ anti-CA), endogenous and
exogenous ALIX expression levels (panel 4, anti-
ALIX), and cellular GAPDH levels (panel 5, anti-
GAPDH). Measurements represent mean ± SD
(n = 6). Lane 1 shows EIAV release from control
293T cells expressing endogenous ALIX. Lanes
2–5 show EIAV produced in cells depleted of
endogenous ALIX and cotransfected with an
empty vector (empty, control, lane 2), or with
vectors expressing siRNA-resistant wild-type ALIX
(WT, control, lane 3), ALIXI212D (I212D, CHMP4
binding control, lane 4), or ALIX6A (6A, Ub binding
mutant, lane 5).
See Figure S4 for details.
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ALIX Binds Lys63-Linked Polyubiquitin ChainsQEE (QEE3A), ERE (ERE3A), or both (6A). Mutations in either triad
substantially reduced binding of purified ALIXV to immobilized
P16-Ubn (Figures 3D and 3E), and mutation of both triads
reduced binding to near-background levels (Figure 3D). Simi-
larly, binding of K63 Ub4 to immobilized ALIXV was also substan-
tially reduced by the 6A mutation as assessed in a biosensor
binding analysis (compare Figure 3F with Figure 2D) or by Ub4
affinity capture/AQUA under conditions of competitive equilib-
rium binding (Figure 3G). The impaired Ub4 binding resulting
from these Ala substitutions was not due to gross disruption of
the helical structure or impaired thermal stability of the V domain
because the circular dichroism spectra of the mutant proteins
were similar to wild-type ALIXV (Figure S3A). Furthermore, Ala
substitution of residues between the two triads (designated
RE; R446, E449) also substantially reduced binding of purified
ALIXV to immobilized P16-Ubn (Figure S3B) while not disrupting
the helical structure or thermal stability of the V domain (Fig-
ure S3A). These data lead us to propose that a repeating Glu-
rich motif, arranged along the a14 helix between amino acids
Q435 and E460 of ALIX, contributes to linkage-specific polyUb
binding.DevelopmentaUb Binding Mutations Inhibit ALIX Functions
in Retrovirus Budding
HIV-1 budding is promoted primarily through an interaction
between the p6Gag PTAP late assembly domain and the cellular
TSG101/ESCRT-I complex (Martin-Serrano and Neil, 2011;
Usami et al., 2009). Viral infectivity and virion release from
293T cells are therefore severely impaired by a p6Gag PTAPmotif
mutation in the R9 proviral expression construct (termed
HIV-1DPTAP). However, ALIX binds a YPXnL late assembly
domain within p6Gag and can substantially rescue the budding
defects in the HIV-1DPTAP construct when overexpressed (Fisher
et al., 2007; Usami et al., 2007). ALIX overexpression therefore
increases HIV-1DPTAP titers (Figure 4A, panel 1) and virus release,
as reflected by an increase in the release of virion-associated
viral MA and CA proteins into the culture supernatant (panel 2).
This system therefore provides a convenient assay for ALIX func-
tion in HIV-1 budding and was used to test whether the ALIX 6A
mutation that blocked Ub binding in vitro altered the ability of
ALIX to stimulate HIV-1 budding.
Control experiments demonstrated that ALIX stimulation of
virion release and infectivity was lost upon mutation of thel Cell 23, 1247–1254, December 11, 2012 ª2012 Elsevier Inc. 1251
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ALIX Binds Lys63-Linked Polyubiquitin ChainsALIX binding site for the downstream CHMP4/ESCRT-III pro-
teins (ALIXI212D, Figure 4A) or upon mutation of the ALIX binding
site within p6Gag (HIV-1DPTAP, DYP). In the actual experiment, the
ALIX 6A mutant stimulated virus release and infectivity to some
extent (Figure 4A) but was less effective than wild-type ALIX in
stimulating either HIV-1DPTAP infectivity (panel 1) or virion release
(panel 2). Wild-type ALIX and ALIX6A were expressed at equiva-
lent levels (panels 4 and 5), and neither protein altered cellular
expression or proteolytic processing of the viral Gag-derived
proteins, implying that the differences in virion release and infec-
tivity reflected differences in the efficiency of budding.Moreover,
the 6A mutation did not affect the affinity of ALIXV binding to
recombinant GST-p6Gag protein, as measured in a biosensor
analysis (Figure S4A). Thus, the inhibitory effects of this mutation
on ALIX function in HIV-1 release likely resulted from loss of
ALIX-Ub interaction.
Unlike HIV-1, EIAV cannot recruit TSG101/ESCRT-I and
relies on ALIX to bud from cells (Martin-Serrano and Neil, 2011;
Usami et al., 2009). Depletion of endogenous ALIX from 293T
cells therefore potently inhibits both EIAV infectivity (Figure 4B,
panel 1) and virus budding, as measured by release of virion-
associated CA protein (panel 2). EIAV release and infectivity
were fully rescued upon re-expression of wild-type ALIX from
a siRNA-resistant construct, demonstrating that the depletion
was specific and that the system could be used to test ALIX
function. Expression of a siRNA-resistant ALIX6A construct
rescued EIAV release, but the mutant protein was less efficient
than wild-type ALIX. Control experiments demonstrated that
ALIXI212D was inactive in EIAV release, that cellular levels of
EIAV Gag and CA proteins were comparable, and that the exog-
enous ALIX proteins were all expressed at similar levels. Thus,
ALIX function in HIV-1 and EIAV budding is impaired by a muta-
tion in the ALIX V domain that inhibits Ub binding. We conclude
that ALIX normally binds Ub when facilitating retrovirus budding
and that this interaction contributes to the efficiency of ALIX
function.
DISCUSSION
The Coiled-Coil Domain of ALIX Confers PolyUb Binding
ALIX shares structural similarity within an50 residue region that
is homologous to the helical coiled-coil UBAN domain in NEMO
that binds to linear polyUb chains with micromolar affinity.
NEMO contacts each of the two Ub moieties within a bound
linear Ub2molecule in very different ways. The distal Ub is bound
through the canonical hydrophobic patch centered around Ile44,
whereas the proximal Ub is bound primarily through polar inter-
actions between a surface of Ub adjacent to but distinct from the
Ile44 patch and a polar face of NEMO (Rahighi et al., 2009). The
latter binding site is composed of two Arg (R309, R312) and
a triad of Glu residues (E313, E317, E320) that make extensive
contacts with this noncanonical surface of Ub. Despite the afore-
mentioned sequence similarities, there are significant differ-
ences between ALIX and NEMO. Notably, UBAN comprises
a coiled-coil dimer of two identical parallel strands where each
Ub moiety of a linear diUb molecule contacts its binding surface
on the opposite strand of the dimeric unit. By contrast, the a14
helix in ALIX that contains the NEMO homology is one strand
of a coiled-coil helical bundle composed of three dissimilar1252 Developmental Cell 23, 1247–1254, December 11, 2012 ª2012helical strands, and the other two strands do not contain any
obvious Ub binding motifs. Our finding that a second triad
(ERE) in ALIX, which is absent from NEMO, also contributes to
polyUb binding supports the hypothesis that this helical surface
of ALIX may contact more than one K63-linked Ub in a polyUb
chain and suggests an avidity-based binding modality that
magnifies the relatively weak binding affinities intrinsic to the
individual UBDs (Ren and Hurley, 2010; Sims and Cohen,
2009). The spacing between the two triads that we have identi-
fied in ALIX is compatible with the dimensions of both K63 and
linear diUb (Komander et al., 2009).
Our data do not rule out the possibility, however, that addi-
tional Ub binding sites may exist elsewhere in the V domain—
a possibility consistent with our biosensor experiments (Fig-
ure 3F) that show that K63 tetraUb binding to the 6A mutant,
while greatly reduced, is still higher than background. Prelimi-
nary principal component analysis of 40,000 ab initio structural
simulations of monoUb binding to ALIXV identified five regions
with plausible contacts on the V domain at distances feasible
to bridge a tetraUb chain (data not shown). Clearly, structural
analysis of ALIXV-tetraUb complexes, together with more
sophisticated modeling and mutagenesis, will be needed to
define precisely themechanism by which ALIXV binds selectively
to K63 tetraUb. Finally, although we have not observed a role for
ALIXV dimers or higher oligomers in linkage-specific polyUb
binding in vitro, we cannot exclude that such amechanism could
contribute to higher avidity polyUb binding in vivo.
ALIX Ub Binding Functions in Retrovirus Budding
The ESCRT pathway facilitates budding of retroviruses and
many other enveloped viruses whose structural proteins use
late assembly domains to recruit early-acting ESCRT factors,
which in turn recruit the ESCRT-III and VPS4 complexes that
mediate the membrane fission step (Martin-Serrano and Neil,
2011; Usami et al., 2009). The two best-understood late-
assembly domains are the PTAP motif, which binds directly to
the UEV domain of the TSG101 subunit of the ESCRT-I complex,
and the YPXnL motif, which binds directly to the V domain of
ALIX. TSG101 UEV also binds Ub (Sundquist et al., 2004; Teo
et al., 2004), and we show here that the ALIX V domain does
too, extending the parallels between these two viral late domain
pathways. Furthermore, we find that mutations that inhibit the
ALIX-Ub interaction impair the ability of ALIX to function in
HIV-1 and EIAV budding, implying that Ub recognition plays an
important role(s) during the virus budding process (Figure 4).
We do not yet know which ubiquitylated protein(s) is (are)
bound by ALIX during virus budding nor understand the mecha-
nistic consequences of Ub binding. Ub binding frequently leads
to covalent ubiquitylation (Hurley et al., 2006), and this possibility
should now be tested for ALIX, particularly because the protein is
monoubiquitylated in vivo (Erpapazoglou et al., 2012; Votteler
et al., 2009). Ub has long been known to be involved in retrovirus
budding (Martin-Serrano, 2007; Vogt, 2000), and experiments
that implicate the importance of K63 Ub chains in this process
(Strack et al., 2002; Weiss et al., 2010) fit well with our observa-
tion that ALIX binds preferentially to K63-linked chains in vitro.
The relevant targets of ubiquitylation during virus budding
have remained elusive, however, because both retroviral Gag
proteins, such as HIV p6Gag (Gottwein and Kra¨usslich, 2005;Elsevier Inc.
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ALIX Binds Lys63-Linked Polyubiquitin ChainsOtt et al., 2000) and ESCRT factors including ALIX itself (Votteler
et al., 2009), can be ubiquitylated in vivo. Indeed, Ub appears to
play multiple roles in ESCRT-mediated MVB sorting in yeast,
where ubiquitylation of both MVB cargoes and ESCRT factors
is functionally important (Erpapazoglou et al., 2012). Similarly,
we envision that Ub could play multiple roles during viral
budding, with Gag ubiquitylation serving to increase the binding
affinity and recruitment of late domain binding partners like
ESCRT-I and ALIX, and ESCRT factor ubiquitylation serving to
enhance ESCRT machinery assembly or other functions. ALIX
plays a critical role in nucleating the assembly of downstream
CHMP4/ESCRT-III complexes, and this activity is required for
ALIX stimulation of HIV budding (Fisher et al., 2007; Usami
et al., 2007). To perform this role, ALIX apparently must undergo
conformational changes that relieve autoinhibition, expose
ligand binding sites, enhance membrane binding, and promote
protein oligomerization (Pires et al., 2009; Zhai et al., 2011;
Zhou et al., 2009), and we speculate that a subset of these
changes is promoted by Ub binding.
EXPERIMENTAL PROCEDURES
Affinity Capture and Immunoblotting
293T cells were transfected (CaPO4) with 8 mg vector or vector expressing
Strep-ALIX wild-type or DPRR ALIX (gifts of M. Maki, Nagoya, Japan). After
72 hr, cells were harvested and lysed in capture buffer (150 mM NaCl,
20mMHEPES [pH 7.4], 2 mMEDTA, 40mMNEM, 13 protease inhibitor cock-
tail [Roche], and 1% [v/v] Triton X-100). DTT (42 mM) was added shortly after
lysis. Lysates were cleared by centrifugation at 20,0003 g, and Strep-tagged
proteins were captured with immobilized P16-Ubn, P16, or deubiquitylated
P16-Ubn as indicated, washed 23 in capture buffer, eluted in SDS loading
buffer containing 100 mM DTT, and immunoblotted as indicated.
In Vitro Pull-Downs
ALIXV and IsoT (10 mg in 300 ml) were incubated O/N at 4
C with 20 ml immo-
bilized P16-Ubn, or P16 in binding buffer (20 mM HEPES [pH 7.4], 150 mM
NaCl, 2 mM EDTA, 1 DTT). Resins were washed 23 and eluted in SDS loading
buffer containing 100 mM DTT. Reciprocal pull-downs of autoubiquitylated
GST-DC2Rsp5 were performed in the same fashion using purified ALIXV,
IsoT, and hPlic2UBA immobilized on Affigel10 resin at 1 mg/ml.
Competitive Ub Binding Reactions
Biotin-tagged TUBE UBA or ALIXV (50 mg) was incubated with a mixture of
8 mg each of K48, K63, and linear Ub4 chains in 300 ml binding buffer over-
night at 4C. A total of 20 ml of streptavidin-agarose was then added and incu-
bated for 1 hr at 4C. The resin was washed 23 in binding buffer, 23 in 50 mM
NH4HCO3 (pH 8.0) containing 50 ml 0.1% RapiGest (Waters) in 50 mM
NH4HCO3 with 10 pmol of synthetic AQUA peptide standards, and 1 mg trypsin
and incubated overnight at 37C. After hydrolysis of RapiGest with HCl,
samples were separated on a C-18 reversed-phase column and directly
analyzed by inline ESI-TOF MS Ub AQUA (see Supplemental Experimental
Procedures).
Rescue of HIVDPTAP Release and Infectivity
293T cells were cotransfected (Lipofectamine 2000) with 1 mg of a proviral
expression construct (HIVDPTAP, WISP01-108 or HIVDPTAP/DYP, WISP05-
124) (Fisher et al., 2007; Garrus et al., 2001) and 1 mg of either empty control
pCI-neo or a pCI-neo vector that expressed either wild-type or mutant ALIX
proteins (WT ALIX, WISP12-84; ALIXI212D, WISP05-117, ALIX6A, WISP12-85)
(Fisher et al., 2007). Cells and virion-containing culture supernatants were
harvested at 48 hr, and viral titers were measured in triplicate using single-
cycle MAGIC assays in HeLaP4 cells. Virions were collected by pelleting
through 20% sucrose at 15,000 3 g. Cells were lysed with 50 mM Tris
(pH 7.4), 150 mM NaCl, 1% Triton X-100, protease inhibitor cocktail (Roche),
and cleared by centrifugation at 15,000 3 g. Immunoblots were probed withDevelopmentarabbit anti-HIV CA (UT 416) and MA (UT 556) antisera, rabbit anti-ALIX
(UT 324), mouse anti-FLAG-M2, mouse anti-GAPDH. Secondary antibodies
were anti-mouse IgG (goat) conjugated to Alexa 680 or anti-rabbit IgG (donkey)
conjugated to IRdye800.
Rescue of EIAV Release and Infectivity
293T cells were transfected after the following time courses: t = 0, seed 2 3
105 cells/well in 6-well plates; t = 24 hr, transfect cells with siRNA using
RNAiMax (sense sequence GAACAAAUGCAGUGAUAUAtt, 10 nM siRNA,
7.5 ml Lipofectamine RNAiMax; Invitrogen); t = 48 hr, change media, and
cotransfect cells with siRNA (10 nM siRNA), pCMVD3 vector, or pCMVD3
expressing siRNA-resistant ALIX (wild-type pCMVD3-ALIX, WISP12-86;
pCMVD3-ALIXI212D, WISP12-87; or pCMVD3-ALIX6A, WISP12-88) and an
EIAV vector comprising 0.2 mg pEV53, 0.2 mg pSIN6.1CeGFPW and
0.075 mg phCMV- VSV-G (Olsen, 1998; Yee et al., 1994) using 10 ml Lipofect-
amine 2000; t = 72 hr, media change (2 ml); and t = 96 hr, harvest cells, and
culture supernatants for analysis as described above (rabbit anti-EIAV,
UT418).SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, two tables, and Supplemental
Experimental Procedures and can be found with this article online at http://dx.
doi.org/10.1016/j.devcel.2012.10.023.
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